|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2004-3-30
|
|
pubmed:abstractText |
We conducted a prospectively randomized clinical trial to compare the efficacy of three outpatient therapy regimens in 341 patients with progressive metastatic renal cell carcinoma.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AtzpodienJJ,
pubmed-author:BergmannLL,
pubmed-author:BodensteinHH,
pubmed-author:FornaraPP,
pubmed-author:HeynemannHH,
pubmed-author:JonasUU,
pubmed-author:KirchnerHH,
pubmed-author:LoeningS ASA,
pubmed-author:MüllerS CSC,
pubmed-author:MetznerBB,
pubmed-author:ObernederRR,
pubmed-author:PomerSS,
pubmed-author:Prospectively Randomized Trial of the German Cooperative Renal...,
pubmed-author:PuchbergerTT,
pubmed-author:RebmannUU,
pubmed-author:ReitzMM,
pubmed-author:RoigasJJ,
pubmed-author:SchottHH,
pubmed-author:SiebelsMM,
pubmed-author:WandertTT
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1188-94
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14981107-Adult,
pubmed-meshheading:14981107-Aged,
pubmed-meshheading:14981107-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14981107-Carcinoma, Renal Cell,
pubmed-meshheading:14981107-Disease-Free Survival,
pubmed-meshheading:14981107-Female,
pubmed-meshheading:14981107-Fluorouracil,
pubmed-meshheading:14981107-Humans,
pubmed-meshheading:14981107-Immunotherapy,
pubmed-meshheading:14981107-Infusions, Intravenous,
pubmed-meshheading:14981107-Injections, Subcutaneous,
pubmed-meshheading:14981107-Interferon-alpha,
pubmed-meshheading:14981107-Interleukin-2,
pubmed-meshheading:14981107-Isotretinoin,
pubmed-meshheading:14981107-Kidney Neoplasms,
pubmed-meshheading:14981107-Male,
pubmed-meshheading:14981107-Middle Aged,
pubmed-meshheading:14981107-Prospective Studies,
pubmed-meshheading:14981107-Recombinant Proteins,
pubmed-meshheading:14981107-Survival Rate,
pubmed-meshheading:14981107-Treatment Outcome,
pubmed-meshheading:14981107-Vinblastine
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).
|
|
pubmed:affiliation |
Medizinische Hochschule Hannover, Germany. Sekrprofatzpodien@yahoo.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
